Due to sample size limitations, few studies have specifically analyzed sex differences in AD penetrance, symptom onset, clinical progression, and the biomarker sequence in APOE4 homozygotes (Fortea et al., 2024; Jansen et al., 2022; Zou et al., 2023). Here, APOE is linked to Alzheimer disease.